Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Belgium extends breast cancer screening:

This article was originally published in Clinica

Executive Summary

The Belgian government is allocating BFr480 million ($10 million) to extend its breast cancer screening programme to women aged between 50 and 69. Screening will begin in January and women of this age group will be tested every two years. A databank will be established to monitor the success of the scheme. Several other countries in Europe, including the UK, have recently extended breast cancer screening to older women than has traditionally been offered by the service. Spain is currently calling for screening for the group aged 45-50. News of the Belgian funding allocation has also sparked off a row over the role of mobile screening centres.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT074937

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel